| Q44660648 | Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. |
| Q80470292 | Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation |
| Q46657615 | Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death |
| Q36666906 | Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation |
| Q33930084 | Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients |
| Q83067863 | C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts |
| Q45092670 | Campath-1H in renal transplantation: The University of Wisconsin experience. |
| Q44461489 | Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. |
| Q44460453 | Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts |
| Q36067827 | Differential outcomes of expanded-criteria donor renal allografts according to recipient age |
| Q80849855 | Donation after cardiac death: the University of Wisconsin experience |
| Q44357602 | Liver transplantation at the University of Wisconsin. |
| Q80604210 | Long-term outcomes in simultaneous pancreas-kidney transplantation: lessons relearned |
| Q51038073 | Luminex-based desensitization protocols: the University of Wisconsin initial experience. |
| Q43153442 | Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients |
| Q84513792 | One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up |
| Q42502255 | Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation |
| Q34891706 | Outcomes of simultaneous liver/kidney transplants are equivalent to kidney transplant alone: a preliminary report |
| Q83366581 | Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes |
| Q43773826 | Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation |
| Q36028239 | Simultaneous pancreas and kidney (SPK) retransplantation in prior SPK recipients |
| Q36294825 | Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. |
| Q45171042 | Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors |
| Q35032293 | Surgical repair of transplant renal artery stenosis with preserved cadaveric iliac artery grafts |
| Q42977139 | The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience. |
| Q42597997 | Underutilization of pancreas donors. |